Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Genetic vaccines are emerging as promising methodologies to elicit immune responses against a wide variety of antigens.
The report details the trend, potential and market size of Emerging Cancer Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Emerging Cancer Vaccinesmarket, defines the market attractiveness level of Emerging Cancer Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Emerging Cancer Vaccines industry, describes the types of Emerging Cancer Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Emerging Cancer Vaccines market and the development prospects and opportunities of Emerging Cancer Vaccines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Emerging Cancer Vaccines market in Chapter 13.
By Player:
Merck
Avax Technologies
Northwest Biotherapeutics
Moderna
GlaxoSmithKline
Antigenics
By Type:
Non Genetic Vaccines
Genetic Vaccines
By End-User:
Cancer Research Centers
Cancer Hospital
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Emerging Cancer Vaccines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Emerging Cancer Vaccines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Emerging Cancer Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Emerging Cancer Vaccines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Emerging Cancer Vaccines Market Analysis and Outlook to 2022
-
7.1 Global Emerging Cancer Vaccines Consumption (2017-2022)
-
7.2 United States Emerging Cancer Vaccines Consumption (2017-2022)
-
7.3 Europe Emerging Cancer Vaccines Consumption (2017-2022)
-
7.4 China Emerging Cancer Vaccines Consumption (2017-2022)
-
7.5 Japan Emerging Cancer Vaccines Consumption (2017-2022)
-
7.6 India Emerging Cancer Vaccines Consumption (2017-2022)
-
7.7 South Korea Emerging Cancer Vaccines Consumption (2017-2022)
8 Region and Country-wise Emerging Cancer Vaccines Market Analysis and Outlook to 2028
-
8.1 Global Emerging Cancer Vaccines Consumption Forecast (2022-2028)
-
8.2 United States Emerging Cancer Vaccines Consumption Forecast (2022-2028)
-
8.3 Europe Emerging Cancer Vaccines Consumption Forecast (2022-2028)
-
8.4 China Emerging Cancer Vaccines Consumption Forecast (2022-2028)
-
8.5 Japan Emerging Cancer Vaccines Consumption Forecast (2022-2028)
-
8.6 India Emerging Cancer Vaccines Consumption Forecast (2022-2028)
-
8.7 South Korea Emerging Cancer Vaccines Consumption Forecast (2022-2028)
9 Global Emerging Cancer Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global Emerging Cancer Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Non Genetic Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Genetic Vaccines Consumption and Growth Rate (2017-2022)
-
9.2 Global Emerging Cancer Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Research Centers Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Emerging Cancer Vaccines Market Outlook by Types and Applications to 2028
-
10.1 Global Emerging Cancer Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Non Genetic Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Genetic Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Emerging Cancer Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Emerging Cancer Vaccines Import and Export Analysis (Top 5 Countries)
-
11.1 Global Emerging Cancer Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Emerging Cancer Vaccines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Emerging Cancer Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Emerging Cancer Vaccines Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Emerging Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Emerging Cancer Vaccines Product and Service
-
14.2 Avax Technologies
-
14.2.1 Avax Technologies Company Details
-
14.2.2 Avax Technologies Emerging Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Avax Technologies Emerging Cancer Vaccines Product and Service
-
14.3 Northwest Biotherapeutics
-
14.3.1 Northwest Biotherapeutics Company Details
-
14.3.2 Northwest Biotherapeutics Emerging Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Northwest Biotherapeutics Emerging Cancer Vaccines Product and Service
-
14.4 Moderna
-
14.4.1 Moderna Company Details
-
14.4.2 Moderna Emerging Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Moderna Emerging Cancer Vaccines Product and Service
-
14.5 GlaxoSmithKline
-
14.5.1 GlaxoSmithKline Company Details
-
14.5.2 GlaxoSmithKline Emerging Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GlaxoSmithKline Emerging Cancer Vaccines Product and Service
-
14.6 Antigenics
-
14.6.1 Antigenics Company Details
-
14.6.2 Antigenics Emerging Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Antigenics Emerging Cancer Vaccines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Emerging Cancer Vaccines
-
Figure Emerging Cancer Vaccines Picture
-
Table Global Emerging Cancer Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Emerging Cancer Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Emerging Cancer Vaccines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Emerging Cancer Vaccines Consumption by Country (2017-2022)
-
Figure United States Emerging Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe Emerging Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
Figure China Emerging Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan Emerging Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India Emerging Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Emerging Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Emerging Cancer Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States Emerging Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Emerging Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Emerging Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Emerging Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Emerging Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Emerging Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non Genetic Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Genetic Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Research Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Non Genetic Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genetic Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Emerging Cancer Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Emerging Cancer Vaccines Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Emerging Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Emerging Cancer Vaccines Product and Service
-
Table Avax Technologies (Foundation Year, Company Profile and etc.)
-
Table Avax Technologies Emerging Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Avax Technologies Emerging Cancer Vaccines Product and Service
-
Table Northwest Biotherapeutics (Foundation Year, Company Profile and etc.)
-
Table Northwest Biotherapeutics Emerging Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Northwest Biotherapeutics Emerging Cancer Vaccines Product and Service
-
Table Moderna (Foundation Year, Company Profile and etc.)
-
Table Moderna Emerging Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Moderna Emerging Cancer Vaccines Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Emerging Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Emerging Cancer Vaccines Product and Service
-
Table Antigenics (Foundation Year, Company Profile and etc.)
-
Table Antigenics Emerging Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Antigenics Emerging Cancer Vaccines Product and Service
-
